Middle Aged Men Finding Success with Health Center’s Miami HRT Therapies


Miami, FL (PRWEB) August 28, 2014

Aging is a part of life. But thanks to the professionals at Elite Health Center, getting older doesnt have to define your lifestyle. Elite Health Center is Miamis premiere mens anti-aging clinic which utilizes the most new and innovative techniques of hormone replacement therapy to help men look and feel their best. The professionals at Elite Health Center evaluate each client to test their hormone levels and determine which course of Miami HRT is best suited for each individual. Based on the results, Elites physicians can construct a health protocol designed to boost hormone levels and help men look and feel years younger.

HRT has been proven to help men overcome a variety of age-related deficiencies including:

NuMale Medical Center Brings to Albuquerque Its Comprehensive, Science-Based Approach to Mens Health


Albuquerque, NM (PRWEB) August 13, 2014

A leading national provider of medical care for mens sexual health and enhancement, NuMale Medical Center, announced the opening of its newest facility today in Albuquerque. This is the companys sixth center, and its first in New Mexico. NuMales Albuquerque facility will continue the companys commitment to employing a safe, science-based approach to treat issues facing men of all ages.

Headed by Chief Medical Officer and founder Dr. Christopher Asandra, M.D., NuMale takes an integrated approach to male sexual health and overall wellness. At NuMale, every patient receives a comprehensive, confidential medical evaluation and consultation on their first visit. This helps the expert doctors at NuMale identify the most appropriate, individually tailored approach to address the patients needs.

NuMale offers a wide array of therapeutic services for men, including:

Best Treatment Erectile Dysfuncion

ALL THE METHODS of Treatment of Erectile Dysfunction in 2 minutes For separate video on each treatment of Erectile Dysfunction contact http://mydoctortells.c…
Video Rating: 5 / 5

Watch more How to Understand Erectile Dysfunction videos: http://www.howcast.com/videos/512021-Uprima-and-Erectile-Dysfunction-Erection-Problems Learn why it…

Testosterone Replacement Therapy Discussed by Personal Injury Lawyer


New York, New York (PRWEB) August 27, 2014

Pharmaceutical product liability lawyer Michael Blom of the national personal injury and wrongful death law firm Levy Konigsberg LLP, with offices in New York, New Jersey, and Georgia, explains legal rights of men who may have suffered a cardiovascular event as a result of taking Testosterone.

According to the article posted on the firms website, Testosterone is a steroid hormone from the androgen group. It is secreted primarily by the testes of males and also small amounts by the adrenal glands. Testosterone is responsible for the development of the testes and prostate, as well as promotion of male sexual characteristics such as increased muscle, bone mass, and growth of body hair.

Attorney Blom, who has also posted a video on the subject, explains that symptoms of a testosterone deficiency may include decreased sex drive, erectile dysfunction, depressed mood, fatigue and loss of energy, and difficulty with memory and concentration. Men may experience a decrease in muscle mass and body hair, and increased body fat. A testosterone deficiency is confirmed with blood work. Testosterone Replacement Therapy (TRT) is used to treat hypogonadism, where there is a deficiency or absence of endogenous testosterone (produced within the body). The testes may not be producing enough testosterone or the hypothalamus and pituitary glands in the brain may not be secreting enough hormones to signal the testes to make testosterone. Prescription testosterone includes patches, topical gels, underarm topical solutions, pellets, and intramuscular injections.

Two recent scientific studies and other medical literature indicate a possible link between the use of testosterone and an increased risk of cardiac death, myocardial infarction, or MI (heart attack), and stroke (1), (2). Injuries may also include pulmonary embolism, or PE (blood clot in artery of the lungs), deep vein thrombosis, or DVT (blood clot in a deep vein, usually the legs), venous thromboembolism (blood clots in the veins, including DVT and PE), central venous thrombosis (blood clot that forms in the brain), retinal venous occlusion (blood clot in the retinal eye vein), and others.

In January, the FDA issued a drug safety communication regarding testosterone products and an increased risk of cardiovascular events, and will communicate the final conclusions and recommendations when the evaluation is complete (3).

In June, the FDA announced they will require manufacturers to include a more general warning about the risk of blood clots in the veins (4). The risk of venous blood clots are already included in the labeling as a possible consequence of polycythemia, an abnormal increase in red blood cells that sometimes occurs with TRT. But, there have been post market reports of venous blood clots unrelated to polycythemia. The new change is to ensure the risk is described consistently in the labeling of all testosterone products. This new warning is not related to the FDAs ongoing evaluation of the possible risk of stroke, heart attack, and death.

The pharmaceutical product liability team at Levy Konigsberg LLP has established a 24/7 hotline for men who suffered a cardiovascular event while they were taking prescription TRT. They can reach the firm toll-free number at (800) 988-8005 or visit the firms website at http://www.levylaw.com to request a free case evaluation.

(1) The Public Library of Science, Jan. 29, 2014:

http://www.plosone.org/article/info:doi/10.1371/journal.pone.0085805

(2) The JAMA Network, Nov. 6, 2013: http://jama.jamanetwork.com/article.aspx?articleid=1764051#Abstract

(3) FDA, Jan. 31, 2014:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

(4) FDA, June 19, 2014: http://www.fda.gov/Drugs/DrugSafety/ucm401746.htm







More Erectile Dysfunction Press Releases

Revealed — how junk food 'controls' you!

Revealed — how junk food 'controls' you!
The researchers believe that a junk diet causes lasting changes in the reward circuit parts of the rats' brain, for example, the orbitofrontal cortex, an area of the brain responsible for decision-making. They said these results may have implications …
Read more on TheHealthSite

One in four with enlarged prostates suffer anxiety and depression, says new study
An enlarged prostate causes urinary problems and may lead to kidney failure in the worst cases. Many men with the condition often wake up … Those with enlarged prostates may also experience erectile dysfunction. In North America, one in three men …
Read more on The Straits Times

Eye changes can predict dementia
dementia A loss of cells in the retina is one of the earliest signs of a form of dementia in people with a genetic risk for the brain disorder – even before any changes appear in their behaviour, says a study. The US Researchers discovered that before …
Read more on TheHealthSite

As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics


New York, New York (PRWEB) July 29, 2014

As testosterone treatment lawsuits (http://www.injurybeacon.com/testosterone-androgel/lawsuit/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that a new study is questioning the effectiveness of these medications in men with Type 2 diabetes. The research, which was published online by The Journal of Clinical Endocrinology & Metabolism on June 30th, involved 88 men who suffered from Type 2 diabetes, all of whom had mild to moderate aging male symptoms and erectile dysfunction. Roughly half of the study subjects were treated with a testosterone injection for 40 weeks, while the remainder received a placebo. Self-administered questionnaires were used at 0, 18 and 40 weeks to measure general health and sexual symptoms.*

During the study, no substantial improvements were seen in the men undergoing low testosterone treatment compared to those who received a placebo. The authors of the article concluded that their findings do not support the use of testosterone therapy to improve general health or sexual symptoms in men who suffer from Type 2 diabetes.

Dozens of testosterone lawsuits currently pending in courts around the country allege that the serious cardiovascular risks associated with low testosterone therapy do not outweigh their benefits. This study would seem to substantiate those claims for this particular patient population, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating testosterone lawsuits on behalf of men who were allegedly suffered heart attacks, strokes, blood clots and other serious cardiovascular problems due to their use of low testosterone therapies.

Testosterone Lawsuits

The safety and effectiveness of testosterone replacement therapy has been under scrutiny since this past January, when the U.S. Food & Drug Administration (FDA) announced it was investigating the cardiovascular side effects associates with this class of medications. The review was prompted by two studies which indicated that older men, as well as those with pre-existing heart disease, were more likely to suffer heart attacks, strokes or death if they were using testosterone medications.

According to a notice posted on the FDAs website, the agency will convene a joint meeting of the Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on September 17, 2014, at which time the members will be asked to make recommendations pertaining to the cardiovascular side effects associated with the medications. The Committees will also address what factors should be considered when deciding whether men need to use low testosterone therapy.*

Since the FDA announced its testosterone safety review, court documents indicate that more than 150 testosterone treatment lawsuits have been filed in U.S. courts. The majority of these claims are pending in the U.S. District Court, Northern District of Illinois, where all federally-filed testosterone lawsuits have been consolidated for coordinated pretrial proceedings. Among other things, plaintiffs in these cases allege that the manufacturers of low testosterone therapies failed to provide doctors and patients with adequate warnings regarding their serious cardiovascular side effects. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other serious cardiovascular problems due to low testosterone therapy may be entitled to file their own testosterone lawsuit. To learn more, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*press.endocrine.org/doi/abs/10.1210/jc.2014-1872, JECM, June 30, 2014

**fda.gov/AdvisoryCommittees/Calendar/ucm404905.htm, FDA, July 17, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.